OMX Stockholm 30
|
2 355,58
|
-17,02
|
-0,72%
|
Analysen zu OMX Stockholm 30-Werten
| 30.01.25 | Volvo AB Buy | Deutsche Bank AG | |
| 30.01.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | ABB Underperform | Bernstein Research | |
| 30.01.25 | Nordea Bank Abp Registered Shs Buy | UBS AG | |
| 30.01.25 | Volvo AB Neutral | UBS AG | |
| 30.01.25 | AstraZeneca Neutral | UBS AG | |
| 30.01.25 | ABB Neutral | UBS AG | |
| 30.01.25 | Nordea Bank Abp Registered Shs Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | Hennes & Mauritz AB Buy | UBS AG | |
| 30.01.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 30.01.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | ABB Sector Perform | RBC Capital Markets | |
| 29.01.25 | Volvo AB Sector Perform | RBC Capital Markets | |
| 29.01.25 | Volvo AB Neutral | UBS AG | |
| 29.01.25 | Ericsson Hold | Deutsche Bank AG | |
| 29.01.25 | Volvo AB Buy | Goldman Sachs Group Inc. | |
| 29.01.25 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | ABB Underperform | Bernstein Research | |
| 27.01.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 27.01.25 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
| 24.01.25 | Ericsson Underweight | Barclays Capital | |
| 24.01.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
| 24.01.25 | Ericsson Sell | Goldman Sachs Group Inc. | |
| 24.01.25 | Ericsson Sell | UBS AG | |
| 23.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 23.01.25 | Volvo AB Neutral | UBS AG | |
| 22.01.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
| 21.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 20.01.25 | ABB Underperform | Bernstein Research | |
| 20.01.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 17.01.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 16.01.25 | Volvo AB Neutral | UBS AG | |
| 16.01.25 | Ericsson Sell | Goldman Sachs Group Inc. | |
| 15.01.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 15.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 13.01.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 13.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 13.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.